Log In
BCIQ
Print this Print this
 

JTE-052

  Manage Alerts
Collapse Summary General Information
Company Japan Tobacco Inc.
DescriptionOral janus kinase (JAK) inhibitor
Molecular Target Janus kinase (JAK)
Mechanism of ActionJanus kinase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/04/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today